- Home
- MUX vs XERS Comparison
MUX vs XERS Comparison
Compare MUX & XERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MUX
- XERS
- Stock Information
- Founded
- MUX 1979
- XERS 2005
- Country
- MUX Canada
- XERS United States
- Employees
- MUX N/A
- XERS N/A
- Industry
- MUX Precious Metals
- XERS Biotechnology: Pharmaceutical Preparations
- Sector
- MUX Basic Materials
- XERS Health Care
- Exchange
- MUX Nasdaq
- XERS Nasdaq
- Market Cap
- MUX 579.8M
- XERS 1.3B
- IPO Year
- MUX N/A
- XERS 2018
- Fundamental
- Price
- MUX $20.10
- XERS $9.16
- Analyst Decision
- MUX Strong Buy
- XERS Strong Buy
- Analyst Count
- MUX 4
- XERS 7
- Target Price
- MUX $19.63
- XERS $8.00
- AVG Volume (30 Days)
- MUX 2.2M
- XERS 2.2M
- Earning Date
- MUX 11-07-2025
- XERS 11-06-2025
- Dividend Yield
- MUX N/A
- XERS N/A
- EPS Growth
- MUX N/A
- XERS N/A
- EPS
- MUX N/A
- XERS N/A
- Revenue
- MUX $168,169,000.00
- XERS $246,025,000.00
- Revenue This Year
- MUX $5.13
- XERS $43.89
- Revenue Next Year
- MUX $19.34
- XERS $20.40
- P/E Ratio
- MUX N/A
- XERS N/A
- Revenue Growth
- MUX N/A
- XERS 35.62
- 52 Week Low
- MUX $6.38
- XERS $2.82
- 52 Week High
- MUX $24.88
- XERS $9.41
- Technical
- Relative Strength Index (RSI)
- MUX 59.78
- XERS 66.26
- Support Level
- MUX $18.80
- XERS $8.99
- Resistance Level
- MUX $22.68
- XERS $9.41
- Average True Range (ATR)
- MUX 1.28
- XERS 0.41
- MACD
- MUX -0.16
- XERS 0.07
- Stochastic Oscillator
- MUX 34.30
- XERS 92.02
About MUX McEwen Mining Inc.
McEwen Inc, formerly McEwen Mining Inc is a mining and minerals production and exploration company that focuses on precious and base minerals in Argentina, Mexico, and the United States. The company generates its revenue from gold and silver production. It owns and operates the wholly-owned El Gallo 1 mine in Mexico and holds a minority stake in the company that manages the San Jose mine in Argentina. More than half of the company's gold output comes from the El Gallo 1 mine, while the remaining gold production and the majority of silver production are sourced from the San Jose mine. Geographically, majority of production occurs in the United States.
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).